Basics INmune Bio Inc. Common stock IPO Date: February 4, 2019 Sector: Healthcare Industry: Biotechnology Market Cap: $56.39M Activated in VL: True Average Daily Range Avg Daily Range: $0.36 | 3.88% Avg Daily Range (30 D): $0.39 | 7.51% Avg Daily Range (90 D): $0.32 | 5.07% Institutional Daily Volume Avg Daily Volume: .24M Avg Daily Volume (30 D): 4.37M Avg Daily Volume (90 D): 1.66M Trade Size Avg Trade Size (Sh.): 115 Avg Trade Size (Sh.) (30 D): 128 Avg Trade Size (Sh.) (90 D): 121 Institutional Trades Total Inst.Trades: 26 Avg Inst. Trade: $1.45M Avg Inst. Trade (30 D): $2M Avg Inst. Trade (90 D): $1.26M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.74M Avg Closing Trade (30 D): $2M Avg Closing Trade (90 D): $1.26M Avg Closing Volume: 185.19K     News Jun 26, 2025 @ 8:00 PM INmune Bio Inc. to Announce Top Line Results from ... Source: Inmune Bio Inc. Jul 19, 2024 @ 9:53 PM Inmune Bio re-elects directors, ratifies auditor -... Source: Natashya Angelica Jul 12, 2024 @ 11:37 AM Zura Bio initiates exchange offer for warrants By ... Source: Ismeta Mujdragic May 30, 2024 @ 12:00 PM INmune Bio Inc. to Join Russell 3000® Index Source: INmune Bio, Inc. May 9, 2024 @ 8:05 PM INmune Bio Inc. Announces First Quarter 2024 Resul... Source: INmune Bio, Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-.43 $-.4 $-2.11 Diluted EPS $-.43 $-.4 $-2.11 Revenue $ .05M $ M $ .01M Gross Profit $ $ $ Net Income / Loss $ -9.74M $ -9.22M $ -42.08M Operating Income / Loss $ -9.91M $ -9.47M $ -42.64M Cost of Revenue $ $ $ Net Cash Flow $ .04M $ -.46M $ -.22M PE Ratio